TGFB1 and Insulin resistance: Improved insulin resistance and glucose tolerance; slowed down the progression of renal interstitial fibrosis; decreased LPS-induced inflammatory cytokine levels and TGF-β1-induced fibroblast activation; and modulated the dysbiosis of gut microbiota